I called in on C-Span and asked peter brookes (heritage foundation) about BAXTER

[sociostudent]

isn't it newstips@

and Baxter confirmed? Many times? Good - thanks.

Ok, I sent an email. 

[sociostudent]

Here's part 1 of the 2-part series (#2 uploading now):
http://vids.rationalveracity.com/v/863,2009-h1n1-vaccine:-big-pharma,-adjuvants,-and-eugenics-%28part-1%29.html

[luckee1]

Is there any way Alex could cover this under activism?  That would inspire many!!  WTG sociostudent!!  You go girl!!!

[sociostudent]

No, it's ok. I already sent an email about it. Never mind.

[sociostudent]

Here's part 2 (10x better than part 1, I used all the info I had at the time, I have even more now but oh well):
http://vids.rationalveracity.com/v/865,2009-h1n1-vaccine:-big-pharma,-adjuvants,-and-eugenics-%28part-2%29.html

[sociostudent]

Is anyone else able to see it? It's not showing up for me

[sociostudent]

nm, it's showing up now ; it's a little choppy, and the sound's a little zonky, but all in all, it's not too bad.

[luckee1]

nm, it's showing up now ; it's a little choppy, and the sound's a little zonky, but all in all, it's not too bad.

Great job sociostudent, just watched the vid you put up!!!  Awesome!

[sociostudent]

Thanks. It only took me 6 hours to upload it 

[luckee1]

   6?  Geeze!

I am sure, just a short stint compared to the days of labor in your research though, and the compilation.  You got good video of the screens which is really hard to translate to the viewer ( I see so much cheaply or lazily done).  It shows you really cared about getting the information clearly exposed. 

[sociostudent]

  6?  Geeze!

I am sure, just a short stint compared to the days of labor in your research though, and the compilation.  You got good video of the screens which is really hard to translate to the viewer ( I see so much cheaply or lazily done).  It shows you really cared about getting the information clearly exposed. 

Yeah, I'd been working on it for the past week, but it's just the tip of the iceberg regarding the info. I'm telling u, someone didn't want me uploading that video. Youtube usually takes a few days at least before pulling mine, this time it was blocked as soon as it was done processing. Then it took forever to upload to veracity because I was trying to get a clearer picture for the viewer but in a smaller size format using media expresso.... Well, I couldn't.

[deconstructmyhouse]

... And my husband and I bought a new car yesterday...

cash for clunkers?
LOL
seriously, congrats on that. 

[sociostudent]

cash for clunkers?
LOL
seriously, congrats on that. 

Unfortunately, no. Our car's transmission went out all of a sudden and we ended up having to buy a used car for about $2500.

But thanks, anyway. 

[deconstructmyhouse]

bummer, and good luck with your new car!
hope it provides many years of safe transport

[sociostudent]

Ok, with some pressure from Sane, I tried re-uploading to youtube (moment of truth )
http://www.youtube.com/watch?v=8AshNevkOFI

[sociostudent]

(It's "blocked in some countries", and I guess that means the U.S.)

Oh well. Can't say I didn't try. It's still up on veracity. Anyone else know where I can upload it?

[luckee1]

Try here:  http://propagandamatrix.com/forum/index.php

evading grid know all how that works.  You can put the video in a thread there. 

Have you torrented it yet?

[sociostudent]

hey cool, the youtube link's workin

awesome

[2010]

wow... he got owned by the callers.
Lying sack of crap.

[sociostudent]

part 2's working fine: http://www.youtube.com/watch?v=pykWGKpzL-8

Good night, everyone.

[KiwiClare]

part 2's working fine: http://www.youtube.com/watch?v=pykWGKpzL-8

Good night, everyone.

 

Hey, thanks so much for the good work you are doing and for making that phone call sociostudent.  I'm posting the clip elsewhere. 

[Satyagraha]

Nice one sociostudent! Glad to see you on the board again too , it's been a while!


I let Michael Savage have it the other day and plugged the Obama Deception. The topic was "Do illegals cause more accidents and hike up insurance rates for the rest of us". Here is a paraphrased transcript for anyone interested. Unfortunately I couldn't find the freaking audio on the internet to download and save it! They started talking about them not having d/ls too and they should have to get them.

"Well, no, they don't need a D/L or insurance because this is Mexico! Didn't you hear? Bush put it in effect in 2005 and Obama is moving forward with the take over.. err, I mean merger.

And while we're on the subject why are we focusing on illegals and not on whats going on in Washington? Our country is being highjacked by a group of criminal banking cartels who want to implode the economy, consolidate resources and rule us all in the aftermath. They LOVE the illegal aliens because they are bring down the wages, causing panic in the job market and making the average American worry about getting their job taken by an illegal or their insurance rate going up rather than paying attention to what the heck is going on! They did the same thing in 1929 and they are at it again!"

"They did the same thing in 1929 huh? They had illegal alien drivers in 1929?"

"No of course not, but they blew out the stock market, bankrupted the small banks and businesses and purchased them for pennies on the dollar! The same thing is happening today! Watch the Obama Deception free on Google or youtube and see exactly who is running this country and where we're going!!"

"OK. We're talking about illegal aliens raising the cost of insurance. We're going to have to let you go"

He let me go a whole hell of a lot longer than O'Reilly does. I can't get half a second over that prick! And he mutes the callers too to top it all off so you can't talk over him like he does to you!

Good for you! Savage is the WORST - he can't take any criticism, he is abusive to say the least. All of his shows are available as podcasts, so if you know the date, you can get the show via itunes.

[chris jones]

Great job Sociostudent. BUMPED+++++++=

You had this freak on the run, typical PR man for the NSA.

Did you noticed he began to blink almost uncontrolably when the Doctor questioned him. She hit a hard note also, he has been trained to lie, a need to know basis, and they use this on every turn, along with deceit.

Your tops Socio, please keep it up.

[sociostudent]

I think I might have something here, need feedback plz:

"Gibbs, J. S., Malide, D., Hornung, F., Bennink, J. R. & Yewdell, J. W.
(2003). The influenza A virus PB1-F2 protein targets the inner
mitochondrial membrane via a predicted basic amphipathic helix
that disrupts mitochondrial function. J Virol 77, 7214–7224."



http://www.nytimes.com/2009/05/01/health/01origin.html?_r=1&ref=science
The federal Centers for Disease Control and Prevention announced last week that the new virus had pieces of North American swine, bird and human flus and of Eurasian swine flu. Although rumors questioning that are circulating on the Internet, most geneticists believe it is correct.

It is essentially a blend of Eurasian swine flu and North American swine flu, but Western hemisphere strains have had an avian segment on the PB2 gene for at least 10 years and a human component on the PB1 gene since 1993, said Henry L. Niman, a biochemist who tracks flu mutations. “The original report is correct,” Dr. Niman said of the C.D.C.’s analysis. The rumors, he added in an e-mail message, stem from “someone who really doesn’t know how to analyze sequences (or is being misquoted.)”

It presumably is in pigs somewhere, perhaps in Mexico. The 1918 human H1N1 established itself in pigs by 1930. But, as Dr. Niman pointed out, it could be only in humans now — or even in a ferret.

The next question, said Dr. Robert G. Webster, a virologist at St. Jude Children’s Research Hospital, is: “How did this virus get in? Is Mexico importing swine from Europe?
While some scientists looking at the virus genome debated its origin, Peter Palese, chairman of microbiology at Mt. Sinai School of Medicine, found cause for optimism about the future. All the pandemic viruses of the last century — the 1918, 1957 and 1968 flus — had a mutation in the gene coding for a protein known as PB1-F2 that is thought to make a virus more lethal. The mutation, he said, is not in the new strain.

Dr. Niman, looking at the same sequences, saw a mutation that, at the same position in H5N1, appeared to speed the virus’s spread in Egypt. "


http://ahrcanum.wordpress.com/2009/07/23/baxter-vaccine-patent-h1n1/
"One thought from http://www.naturalnews.com/026141.html  notes,” it is astonishing to realize, because for this to have been a natural combination of viral fragments, it means an infected bird from North America  would have had to infect pigs in Europe, then be re-infected by those some pigs with an unlikely cross-species mutation that allowed the bird to carry it again, then that bird would have had to fly to Asia and infected pigs there, and those Asian pigs then mutated the virus once again (while preserving the European swine and bird  elements) to become human transmittable, and then a human would have had to catch that virus from the Asian pigs — in Mexico! — and spread it to others in order to assist the World Health Organization in developing a new vaccine, reaping billions in the process. ” "
"Just 50 miles from the H1N1 ground zero outbreak in Mexico City, lies Baxter’s manufacturing plant in Cuernavaca, Mexico.  It was named one of the 10 Best Plants in North America for 2008 by Industry Week magazine. http://www.baxter.com/about_baxter/news_room/news_releases/2008/12_19_08_industryweek.html  The plant manufactures, “Water For Injection, Devices Medical, Premixes Formulations,” according to  http://www.alibaba.com/member/juanbaxter/aboutus.html . What else do they manufacture there?  What kind of water gets injected?  Germ Warfare? Bio Hazards? Virus Mutations? Vaccines? Cures or Causes?

The National Autonomous University of Mexico (UNAM) has a satellite campus located in Cuernavaca, which is aimed at research and graduate studies. It also has an undergraduate program in genomics.  Cuernavaca is the home of the following research centers: Center for Genomic Sciences (UNAM),[3] the Institute of Biotechnology (UNAM),[4] the Institute of Physical Sciences (UNAM),[5] the Center for research in Energy (UNAM), the Institute of Mathematics (UNAM), the Center for Research in Engineering and Applied Sciences (UAEM),[6] and the National Institute of Public Health. Cuernavaca has the highest concentration of scientists and researchers in Latin America. -WIKI http://en.wikipedia.org/wiki/Cuernavaca  Cuernavaca is certainly a who’s who in genetics and research.

Certainly someone or some government knows how to engineer and unleash such deadly viruses, but the implication is horrendous. Equally horrific is that Americans could be subject to compulsory vaccinations and possible detention thanks to Patriot Act I, Patriot II, BARDA, BioShield I, BioShield II,  BARDA, Federal or State Emergency Medical Powers Acts, FEMA, and the most recent announcement of a Health Emergency from DHS and a level 5 pandemic level designation from WHO."

Why, if the PB1F2 gene (which is supposedly responsible for disrupting mitochondrial function) is inactive at this time, why are we even freaking out about this?

[TahoeBlue]

I think I might have something here, need feedback plz:

Go over CDC created this hybrid flu years ago--CDC/Baxter/Schering-Plough/Merck 

It goes over timeline  - synthetic viruses - Biotech manufacturers in mexico (Baxter - GSK - Sanofi)

[sociostudent]

Go over CDC created this hybrid flu years ago--CDC/Baxter/Schering-Plough/Merck 

It goes over timeline  - synthetic viruses - Biotech manufacturers in mexico (Baxter - GSK - Sanofi)

Awesome, thanks!

[TahoeBlue]

Awesome, thanks!

A little more:

Oct 2004 - ("Official") Reconstruction of 1918 Swine Flu virus

http://www.encyclopedia.com/doc/1G1-127713245.html
Serologic evidence of human and swine influenza in Mayan persons.(Dispatches)  January 1, 2005
Antibodies against influenza viruses were detected in 115 serum samples from indigenous Mayan persons from Kochol, Yucatan. Seropositivity rates were 26.9% to A/Bayern/7/95, 40.8% to A/Sydney/5/97, 1.7% to A/Swine/ Wisconsin/238/97, and 79.1% to A/Swine/Minnesota/ 593/99.
This report is the first in Mexico of the prevalence of antibodies to swine influenza virus in humans.

BioTechs in mexico:

ttp://www.drugresearcher.com/Research-management/GSK-purchases-Wyeth-s-vaccine-facility
GSK purchases Wyeth's vaccine facility By Wai Lang Chu, 02-Sep-2005

Britiain's largest drugsmaker, GlaxoSmithKline, announced it is to expand its ability to increase vaccines supplies by acquiring a vaccine research and production facility from rivals Wyeth

The 90-acre manufacturing site, located in Marietta, Pennsylvania, which Wyeth closed in December, will be used to help develop future vaccines for GlaxoSmithKline. Terms of the acquisition were kept confidential

http://www.manattjones.com/newsletters/newsbrief/20070930.htm
Roche Inaugurates Facility In Toluca - September 26, 2007

The Mexican subsidiary of Swiss Pharmaceutical company Roche, Grupo Roche Syntex de Mexico, inaugurated a USD 60 million facility to produce high-powered drugs to treat cancer, transplants and osteoporosis among other diseases

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/70050&EDATE=
President of Mexico Keynote Speaker As Schering-Plough Mexico Dedicates Pharmaceutical Manufacturing Facility      XOCHIMILCO, Mexico, Feb. 28

http://www.thepoultrysite.com/poultrynews/14871/intervet-scheringplough-animal-health-appoints-executive-team
Intervet/Schering-Plough Animal Health appoints Executive Team May 14, 2008

http://www.merck.com/newsroom/press_releases/corporate/2009_0309.html
03/09/2009 MERCK AND SCHERING-PLOUGH TO MERGE for 41.1 billion


http://www.baxter.com/about_baxter/news_room/news_releases/2008/12_19_08_industryweek.html
Baxter Plant in Mexico Named Among IndustryWeek's Top 10 Best Plants  - December 19, 2008

DEERFIELD, Ill., December 19, 2008 — Baxter’s manufacturing plant in Cuernavaca, Mexico has been named one of the 10 Best Plants in North America for 2008 by IndustryWeek magazine. Winners of the competition were selected based on key performance metrics, as well as dedication to continually improving people and processes.

http://www.worldpharmanews.com/content/view/719/30/
Sanofi-aventis invests €100 million in new facility in Mexico - Thursday, 12 March 2009  
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), has announced the signing of an agreement with the Mexican authorities to build a € 100 million facility to manufacture influenza vaccine in Mexico. The announcement was made during a ceremony attended by Felipe Calderon, President of Mexico, and Nicolas Sarkozy, President of France, who was in Mexico City for a State visit.

Protein Sciences Inks Deal to Run A Manufacturing Facility in the Country [Mexico] 05/7/2009http://investing.businessweek.com/businessweek/research/stocks/private/snapshot.asp?privcapId=159397

Protein Sciences Corporation announced that it has signed a deal with the Mexican regulator to run a manufacturing facility in the country. The company did not disclose the terms and conditions of the deal. The company has not committed to making Influenza A H1N1 (swine 'flu) vaccine, however the factory may be used to make a seasonal 'flu vaccine that the firm hopes to launch in the country this year.

[sociostudent]

A little more:

Oct 2004 - ("Official") Reconstruction of 1918 Swine Flu virus

http://www.encyclopedia.com/doc/1G1-127713245.html

Serologic evidence of human and swine influenza in Mayan persons.(Dispatches)  January 1, 2005
Antibodies against influenza viruses were detected in 115 serum samples from indigenous Mayan persons from Kochol, Yucatan. Seropositivity rates were 26.9% to A/Bayern/7/95, 40.8% to A/Sydney/5/97, 1.7% to A/Swine/ Wisconsin/238/97, and 79.1% to A/Swine/Minnesota/ 593/99.
This report is the first in Mexico of the prevalence of antibodies to swine influenza virus in humans.

BioTechs in mexico:

http://www.drugresearcher.com/Research-management/GSK-purchases-Wyeth-s-vaccine-facility
GSK purchases Wyeth's vaccine facility By Wai Lang Chu, 02-Sep-2005

Britiain's largest drugsmaker, GlaxoSmithKline, announced it is to expand its ability to increase vaccines supplies by acquiring a vaccine research and production facility from rivals Wyeth

http://www.manattjones.com/newsletters/newsbrief/20070930.htm
Roche Inaugurates Facility In Toluca - September 26, 2007

The Mexican subsidiary of Swiss Pharmaceutical company Roche, Grupo Roche Syntex de Mexico, inaugurated a USD 60 million facility to produce high-powered drugs to treat cancer, transplants and osteoporosis among other diseases

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/70050&EDATE=
President of Mexico Keynote Speaker As Schering-Plough Mexico Dedicates Pharmaceutical Manufacturing Facility      XOCHIMILCO, Mexico, Feb. 28

http://www.thepoultrysite.com/poultrynews/14871/intervet-scheringplough-animal-health-appoints-executive-team
Intervet/Schering-Plough Animal Health appoints Executive Team May 14, 2008

http://www.merck.com/newsroom/press_releases/corporate/2009_0309.html
03/09/2009 MERCK AND SCHERING-PLOUGH TO MERGE for 41.1 billion


http://www.baxter.com/about_baxter/news_room/news_releases/2008/12_19_08_industryweek.html

Baxter Plant in Mexico Named Among IndustryWeek's Top 10 Best Plants  - December 19, 2008

DEERFIELD, Ill., December 19, 2008 — Baxter’s manufacturing plant in Cuernavaca, Mexico has been named one of the 10 Best Plants in North America for 2008 by IndustryWeek magazine. Winners of the competition were selected based on key performance metrics, as well as dedication to continually improving people and processes.

http://www.worldpharmanews.com/content/view/719/30/
Sanofi-aventis invests €100 million in new facility in Mexico   Thursday, 12 March 2009 
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), has announced the signing of an agreement with the Mexican authorities to build a € 100 million facility to manufacture influenza vaccine in Mexico. The announcement was made during a ceremony attended by Felipe Calderon, President of Mexico, and Nicolas Sarkozy, President of France, who was in Mexico City for a State visit.
Protein Sciences Inks Deal to Run A Manufacturing Facility in the Country [Mexico]
05/7/2009

http://investing.businessweek.com/businessweek/research/stocks/private/snapshot.asp?privcapId=159397
Protein Sciences Corporation announced that it has signed a deal with the Mexican regulator to run a manufacturing facility in the country. The company did not disclose the terms and conditions of the deal. The company has not committed to making Influenza A H1N1 (swine 'flu) vaccine, however the factory may be used to make a seasonal 'flu vaccine that the firm hopes to launch in the country this year.

[sociostudent]

And she's Hott to boot.  Make's me want to listen to Tom Petty's American Girl.

Thanks, but I'm thinking more The Doors' "The End":
http://www.drugresearcher.com/Emerging-targets/GSK-erodes-pipeline-across-several-areas
GSK erodes pipeline across several areas
By Mike Nagle, 05-Mar-2007

Related topics: Emerging targets, Drug discovery

GlaxoSmithKline (GSK) has stopped development of several drugs, leaving some industry experts to wonder if the company's cap on research spending is stifling drug development.

The pharma giant published its annual report last Friday, revealing that it has dropped 11 phase II compounds. The potential loss in future revenue is "only partially offset by the emergence of seven commercially significant novel Phase II compounds," according to Dr Andrew Baum, an analyst at Morgan Stanley.

Over recent years, R&D costs have rocketed - it now costs a pharma company over $800m (€611m) per approved drug. Coupled with several challenges facing the industry, for example increased generic competition, several pharma giants have recently reassessed their pipelines and business models.

"Our pre-existing concerns over the strength of GSK's much hyped pipeline have grown following publication of the companies revised pipeline," said Dr Baum. He estimates that dropping the drugs will cost GSK around $2.3bn in lost revenue in 2013. New compounds into Phase II will be worth around $975m, leaving GSK with a potential short fall of $1.3bn.

He continued: "We continue to wonder whether GSK's self imposed near term R&D cap is slowing pipeline progression."

The biggest single loss to revenue comes from dropping odiparcil, an indirect thrombin inhibitor that was developed to prevent blood clots related to cardiovascular disease. Morgan Stanley estimated the compound could have been worth $338m in 2013.

A further $225m reduction in potential sales could result from the decision to cease development of the Type II diabetes drug, solabegron. The drug is aimed at activating a protein called beta-3 adrenergic receptor in order to enhance lipolysis - the process by which the body breaks down stored fat and releases glycerol. However, the drug will continue to be developed as a possible treatment for overactive bladder and irritable bladder syndrome.

Other drugs dropped from GSK's pipeline were combination therapy, vesipitant and paroxetine for depression and anxiety and four anti-cancer drugs.

"While product failure is inevitable, the contraction of GSK's oncology pipeline is a potential concern given the significant in-licensing investment in this area," said Dr Baum.

The four oncology drugs were: ethynylcytidine, a selective RNA polymerase inhibitor to treat solid tumours; iboctadekin, a recombinant form of human interleukin 18 designed to induce an immune system response against certain susceptible cancers, such as melanoma; ispinesib, a KSP protein inhibitor to treat lung cancer amoung others; vestipitant, an NK1 inhibitor to treat postoperative nausea and vomiting, which was also being tested in combination with Paxil/Seroxat (paroxetine) for depression and anxiety.

"Given the size of GSK's pipeline, we are disappointed to see that only 7 out of 42 commercially significant compounds seem to have advanced into Phase II, compared to last years update," said Dr Baum.

Of the seven, he identifed the key compounds as: 681313 and 856553, which are both p38 kinase inhibitors to treat chronic obstructive pulmonary diesease (COPD) -although the first is also be tested for rheumatoid arthritis, atherosclerosis and pain; albiglutide, which is a glucagon-like peptide activator for the treatment of Type II diabetes; 364735, an HIV integrase inhibitor; and 649868, an orexin inhibtor for insomnia.
http://www.ncbi.nlm.nih.gov/pubmed/12554798
http://www.jleukbio.org/cgi/content/full/73/2/213
http://www.jleukbio.org/cgi/reprint/73/2/213
Interleukin-18.
Gracie JA, Robertson SE, McInnes IB.

Centre for Rheumatic Diseases, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, Scotland, UK.

Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses. IL-18 is expressed at sites of chronic inflammation, in autoimmune diseases, in a variety of cancers, and in the context of numerous infectious diseases. This short review will describe the basic biology of IL-18 and thereafter address its potential effector and regulatory role in several human disease states including autoimmunity and infection. IL-18, previously known as interferon-gamma (IFN-gamma)-inducing factor, was identified as an endotoxin-induced serum factor that stimulated IFN-gamma production by murine splenocytes [(1) ]. IL-18 was cloned from a murine liver cell cDNA library generated from animals primed with heat-killed Propionibacterium acnes and subsequently challenged with lipopolysaccharide [(2) ]. Nucleotide sequencing of murine IL-18 predicted a precursor polypeptide of 192 amino acids lacking a conventional signal peptide and a mature protein of 157 amino acids. Subsequent cloning of human IL-18 cDNA revealed 65% homology with murine IL-18 [(3) ] and showed that both contain an unusual leader sequence consisting of 35 amino acids at their N terminus.

[sociostudent]

"...After stimulation with IL-18, natural killer (NK) cells and certain T cells release another important cytokine called interferon-γ (IFN-γ) or type II interferon that plays an important role in activating the macrophages or other cells.

The combination of this cytokine and IL12 has been shown to inhibit IL4 dependent IgE and IgG1 production, and enhance IgG2a production in B cells. IL-18 binding protein (IL18BP) can specifically interact with this cytokine, and thus negatively regulate its biological activity.[3]
Apart from its physiological role, IL-18 is also able to induce severe inflammatory reactions, which suggests its role in certain inflammatory disorders."
http://en.wikipedia.org/wiki/Interleukin_18